Vega Biotec Private Limited
Vega Biotec Private Limited is a Private Non-govt company company incorporated in 2006 and based in Gujarat, India. Vega Biotec Private Limited operates in Wholesale Trade (NIC 51109) with authorized capital of ₹10.00 L and paid-up capital of ₹10.00 L. For 2022-23, the company reported revenue of ₹30.44 Cr and profit after tax of ₹77.80 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Vega Biotec Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +27d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +28d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Vega Biotec Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 957525023 | Axis Bank Ltd(Bank) | ₹1.87 Cr | 04 Jul 2021 | Satisfied |
| 604708255 | Kotak Mahindra Bank Ltd(Bank) | ₹19.02 Cr | 04 Jul 2022 | Open |
| 697038593 | State Bank of India(Bank) | ₹6.20 Cr | 27 Jan 2021 | Satisfied |
| 788419574 | HDFC Bank Ltd(Bank) | ₹15.61 Cr | 04 Jul 2019 | Open |
| 292169941 | Axis Bank Ltd(Bank) | ₹10.85 Cr | 04 Jul 2021 | Open |
Charge IDs, lenders & amounts for Vega Biotec Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +75.0% | +28.0% | +508.0% | |
| Profit after Tax2022-23 | +53.0% | +16.0% | +451.0% | |
| Net Worth2022-23 | +17.0% | +38.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +1.33% | — | — | +0.71% | — | |||
| 2016-17 | +2.97% | +12.14% | — | +1.82% | — | |||
| 2017-18 | +6.57% | +679.74% | — | +12.21% | — | |||
| 2019-20 | +3.75% | +122.33% | +79.17% | +8.87% | 8.92 | |||
| 2020-21 | +3.52% | +44.13% | +51.73% | +6.38% | 8.11 | |||
| 2021-22 | +2.07% | +37.41% | +29.47% | +3.12% | 9.46 | |||
| 2022-23 | +2.56% | +58.15% | +36.56% | +4.79% | 7.63 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 54,42,952 | 82.86% |
| Institutional Investors | 1 | 5,27,788 | 8.03% |
| Public & Others | 49 | 5,98,060 | 9.10% |
Promoter, institutional & public holding for Vega Biotec Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
38 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.